Go Pro
→ CODE RED: AI Meltdown Imminent? (From Paradigm Press) (Ad)tc pixel Free CAN Stock Alerts

Canaan (CAN) Financials

Canaan logo
$0.27 -0.01 (-1.92%)
Closing price 07/20/2026 04:00 PM Eastern
Extended Trading
$0.27 +0.00 (+1.09%)
As of 04:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Canaan

Annual Income Statements for Canaan

This table shows Canaan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 58 8.33 -147 -37 314 70 -414 -250 -210
Consolidated Net Income / (Loss)		 58 18 -149 -33 309 70 -414 -250 -210
Net Income / (Loss) Continuing Operations		 58 18 -149 -33 309 70 -414 -250 -210
Total Pre-Tax Income 		62 29 -149 -33 317 88 -465 -172 -207
Total Operating Income		 55 19 -151 -39 283 43 -411 -227 -112
Total Gross Profit		 93 74 -74 5.81 442 230 -241 -84 41
Total Revenue		 201 394 204 69 773 652 211 269 530
Operating Revenue		 201 394 204 69 772 652 211 269 530
Total Cost of Revenue		 108 320 278 63 331 421 452 354 489
Operating Cost of Revenue		 108 320 278 63 331 421 452 354 489
Total Operating Expenses		 38 55 77 45 159 187 170 143 153
Selling, General & Admin Expense		 19 21 50 20 91 88 71 72 68
Marketing Expense		 3.18 5.64 3.15 3.07 16 9.41 8.18 5.71 14
Research & Development Expense		 15 28 24 22 52 82 65 61 63
Impairment Charge		 - - - - 0.00 7.88 26 11 10
Other Special Charges / (Income)		 - - - - - 0.00 0.00 -7.22 -1.58
Total Other Income / (Expense), net		 6.50 9.78 2.88 5.97 35 45 -55 55 -95
Interest Expense		 0.00 7.72 2.88 0.55 - 0.00 0.00 0.52 1.97
Interest & Investment Income		 0.90 1.08 0.99 1.38 1.18 2.37 0.96 0.54 0.27
Other Income / (Expense), net		 5.60 16 4.76 5.13 34 43 -56 55 -94
Income Tax Expense		 3.86 11 0.00 0.00 7.77 18 -51 77 2.78
Basic Earnings per Share		 $19.06 $6.23 ($48.05) ($9.17) $12.26 $2.73 ($16.06) ($6.13) ($2.99)
Weighted Average Basic Shares Outstanding		 1.97B 1.96B 2.15B 2.35B 2.52B 2.56B 2.58B 4.07B 7.04B
Diluted Earnings per Share		 $19.06 $6.19 ($48.05) ($9.17) $12.00 $2.71 ($16.06) ($6.13) ($2.99)
Weighted Average Diluted Shares Outstanding		 1.97B 1.98B 2.15B 2.35B 2.58B 2.58B 2.58B 4.07B 7.04B
Weighted Average Basic & Diluted Shares Outstanding		 - - 2.37B 2.37B 2.80B 2.80B 3.77B 5.59B 10.74B

Quarterly Income Statements for Canaan

No quarterly income statements for Canaan are available.

Annual Cash Flow Statements for Canaan

This table details how cash moves in and out of Canaan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 24 53 -2.65 -18 342 -247 6.01 1.46 -17
Net Cash From Operating Activities		 14 -1.85 -40 6.51 202 -183 -124 -199 -271
Net Cash From Continuing Operating Activities		 14 -1.85 -40 6.51 202 -183 -124 -199 -271
Net Income / (Loss) Continuing Operations		 58 18 -149 -33 309 70 -414 -250 -210
Consolidated Net Income / (Loss)		 58 18 -149 -33 309 70 -414 -250 -210
Depreciation Expense		 1.39 1.91 4.90 4.81 2.19 34 60 28 47
Amortization Expense		 0.00 0.00 - - - 0.00 0.00 0.16 0.21
Non-Cash Adjustments To Reconcile Net Income		 14 1.39 119 3.50 183 -65 258 56 53
Changes in Operating Assets and Liabilities, net		 -59 -23 -16 31 -292 -222 -27 -34 -162
Net Cash From Investing Activities		 -13 12 -2.34 -7.63 0.85 -8.10 40 61 57
Net Cash From Continuing Investing Activities		 -13 12 -2.34 -7.63 0.85 -8.10 40 61 57
Purchase of Property, Plant & Equipment		 -1.94 -3.63 -1.20 -0.33 -5.65 -18 -3.31 -19 -25
Acquisitions		 - - - - - - 0.00 0.00 -12
Sale of Property, Plant & Equipment		 2.12 0.03 0.00 0.10 0.03 0.00 2.30 8.78 0.69
Divestitures		 - - - 0.00 0.00 9.64 41 71 93
Net Cash From Financing Activities		 23 43 40 -17 139 -56 90 140 198
Net Cash From Continuing Financing Activities		 23 43 40 -17 139 -56 90 140 198
Repayment of Debt		 0.00 -140 -163 -33 -5.49 - 0.00 0.00 -17
Repurchase of Preferred Equity		 - 0.00 0.00 -2.48 -3.84 -23 -2.42 -0.77 -1.61
Repurchase of Common Equity		 - 0.00 0.00 -4.74 -17 -44 0.00 0.00 -5.00
Issuance of Debt		 0.00 284 125 23 - 0.00 0.00 9.94 0.00
Issuance of Preferred Equity		 - - - - 0.00 0.00 25 130 100
Issuance of Common Equity		 0.00 0.00 78 0.00 6.99 10 68 0.77 122
Other Financing Activities, net		 23 -101 0.00 0.00 159 - 0.00 0.00 0.00
Cash Interest Paid		 0.00 5.21 1.66 0.57 0.04 0.00 0.00 0.37 1.34
Cash Income Taxes Paid		 0.22 19 0.50 0.00 0.07 45 2.88 0.05 1.44

Quarterly Cash Flow Statements for Canaan

No quarterly cash flow statements for Canaan are available.

Annual Balance Sheets for Canaan

This table presents Canaan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 204 142 159 884 685 493 463 603
Total Current Assets		 199 135 155 828 556 364 334 433
Cash & Equivalents		 38 74 60 421 102 96 96 81
Accounts Receivable		 3.46 0.41 1.10 0.06 0.00 3.00 1.51 19
Inventories, net		 85 28 35 127 212 142 95 181
Prepaid Expenses		 27 30 49 271 243 122 91 100
Other Current Assets		 - - - - - 0.00 51 53
Plant, Property, & Equipment, net		 4.06 3.25 1.88 29 85 29 40 44
Total Noncurrent Assets		 0.92 4.02 2.61 27 44 100 89 126
Noncurrent Note & Lease Receivables		 - - - - - 0.00 19 35
Intangible Assets		 - - - - - 0.00 0.90 0.69
Noncurrent Deferred & Refundable Income Taxes		 - - 0.00 16 22 67 0.30 0.19
Other Noncurrent Operating Assets		 0.92 4.02 2.61 8.50 22 33 69 90
Total Liabilities & Shareholders' Equity		 204 142 159 884 685 493 463 603
Total Liabilities		 169 43 93 341 77 145 197 166
Total Current Liabilities		 169 41 91 327 75 135 179 131
Short-Term Debt		 153 18 7.49 - - 0.00 17 29
Accounts Payable		 6.88 14 5.75 23 17 6.25 14 26
Accrued Expenses		 8.43 5.84 9.74 69 48 64 43 55
Current Deferred & Payable Income Tax Liabilities		 0.09 - 0.00 23 7.23 3.53 11 11
Other Current Liabilities		 1.00 2.60 68 213 2.98 61 94 11
Total Noncurrent Liabilities		 0.00 1.92 1.74 14 2.04 9.92 18 34
Long-Term Debt		 - - - - - 0.00 7.28 24
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - 0.00 0.15 0.12
Other Noncurrent Operating Liabilities		 0.00 1.92 1.74 14 2.04 9.92 11 11
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 35 99 67 543 608 348 266 437
Total Preferred & Common Equity		 35 99 67 543 608 348 266 437
Total Common Equity		 35 99 67 543 608 348 266 437
Common Stock		 23 234 251 454 492 654 816 1,177
Retained Earnings		 7.85 -141 -184 126 195 -220 -450 -661
Treasury Stock		 0.00 0.00 -3.68 -36 -57 -57 -57 -37
Accumulated Other Comprehensive Income / (Loss)		 -9.49 -7.97 -12 -16 -37 -44 -57 -57
Other Equity Adjustments		 14 14 15 15 15 15 15 15

Quarterly Balance Sheets for Canaan

No quarterly balance sheets for Canaan are available.

Annual Metrics And Ratios for Canaan

This table displays calculated financial ratios and metrics derived from Canaan's official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 0.00 2,372,222,222.00 2,372,222,222.00 2,804,138,492.00 2,804,138,492.00 3,772,078,667.00 - 10,743,107,417.00
DEI Adjusted Shares Outstanding		 0.00 0.00 2,372,222,222.00 2,372,222,222.00 2,804,138,492.00 2,804,138,492.00 3,772,078,667.00 - 10,743,107,417.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -0.06 -0.02 0.11 0.02 -0.11 - -0.02
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 96.17% -48.13% -66.29% 1,022.28% -15.69% -67.54% 27.35% 96.69%
EBITDA Growth		 0.00% -39.21% -475.91% 79.46% 1,196.28% -62.51% -440.00% 64.63% -9.98%
EBIT Growth		 0.00% -40.96% -509.70% 76.87% 1,034.50% -72.88% -642.62% 63.06% -19.45%
NOPAT Growth		 0.00% -77.05% -995.27% 74.21% 1,109.88% -87.69% -946.71% 44.72% 50.59%
Net Income Growth		 0.00% -69.10% -933.50% 77.73% 1,034.29% -77.39% -692.63% 39.70% 15.81%
EPS Growth		 0.00% -67.52% -876.25% 80.92% 230.86% -77.42% -692.62% 61.83% 51.22%
Operating Cash Flow Growth		 0.00% -113.25% -2,067.92% 116.18% 3,009.41% -190.27% 32.30% -61.19% -36.11%
Free Cash Flow Firm Growth		 0.00% 0.00% 60.23% 125.88% 1,596.71% -314.18% 90.72% -200.17% -191.76%
Invested Capital Growth		 0.00% 0.00% -62.34% -91.31% 3,027.98% 356.20% -50.20% -23.14% 111.06%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 46.20% 18.78% -36.27% 8.44% 57.17% 35.35% -113.86% -31.31% 7.77%
EBITDA Margin		 30.90% 9.58% -69.39% -42.28% 41.30% 18.36% -192.37% -53.42% -29.87%
Operating Margin		 27.42% 4.92% -74.13% -56.71% 36.62% 6.59% -194.29% -84.33% -21.19%
EBIT Margin		 30.21% 9.09% -71.80% -49.25% 41.01% 13.19% -220.57% -63.97% -38.85%
Profit (Net Income) Margin		 28.73% 4.53% -72.72% -48.05% 40.00% 10.73% -195.84% -92.73% -39.69%
Tax Burden Percent		 93.73% 61.14% 100.00% 100.00% 97.55% 79.11% 88.97% 144.98% 101.34%
Interest Burden Percent		 101.48% 81.43% 101.29% 97.55% 99.97% 102.76% 99.80% 99.99% 100.83%
Effective Tax Rate		 6.27% 38.86% 0.00% 0.00% 2.45% 20.89% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 21.84% -142.05% -123.22% 482.21% 11.01% -75.87% -71.34% -26.08%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 38.16% -721.70% -113.76% 468.86% -2.46% 52.13% 36.26% 234.51%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 79.77% -78.74% 83.36% -380.75% 1.14% -10.78% -9.96% -33.69%
Return on Equity (ROE)		 0.00% 101.61% -220.79% -39.86% 101.46% 12.15% -86.66% -81.29% -59.77%
Cash Return on Invested Capital (CROIC)		 0.00% -178.16% -51.47% 44.81% 294.61% -117.07% -8.85% -45.17% -97.49%
Operating Return on Assets (OROA)		 0.00% 17.53% -84.64% -22.48% 60.76% 10.96% -79.18% -36.03% -38.61%
Return on Assets (ROA)		 0.00% 8.73% -85.73% -21.93% 59.26% 8.91% -70.30% -52.23% -39.45%
Return on Common Equity (ROCE)		 0.00% 101.61% -220.79% -39.86% 101.46% 12.15% -86.66% -81.29% -59.77%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 50.81% -149.32% -49.73% 56.95% 11.50% 0.00% -93.80% 0.00%
Net Operating Profit after Tax (NOPAT)		 52 12 -106 -27 276 34 -288 -159 -79
NOPAT Margin		 25.70% 3.01% -51.89% -39.70% 35.72% 5.21% -136.00% -59.03% -14.83%
Net Nonoperating Expense Percent (NNEP)		 0.00% -16.32% 579.65% -9.45% 13.36% 13.47% -128.01% -107.60% -260.59%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - 5.59% -82.60% -54.79% -16.05%
Cost of Revenue to Revenue		 53.80% 81.22% 136.27% 91.56% 42.83% 64.65% 213.86% 131.31% 92.23%
SG&A Expenses to Revenue		 9.58% 5.42% 24.44% 29.40% 11.78% 13.55% 33.69% 26.62% 12.85%
R&D to Revenue		 7.63% 7.01% 11.88% 31.28% 6.75% 12.55% 30.66% 22.77% 11.92%
Operating Expenses to Revenue		 18.79% 13.87% 37.85% 65.15% 20.55% 28.76% 80.43% 53.03% 28.96%
Earnings before Interest and Taxes (EBIT)		 61 36 -147 -34 317 86 -466 -172 -206
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 62 38 -142 -29 319 120 -407 -144 -158
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 2.85 0.61 14.10 1.50 0.63 1.24 1.94 0.59
Price to Tangible Book Value (P/TBV)		 0.00 2.85 0.61 14.10 1.50 0.63 1.24 1.94 0.59
Price to Revenue (P/Rev)		 0.50 0.25 0.30 13.62 1.05 0.59 2.04 1.91 0.49
Price to Earnings (P/E)		 1.73 12.01 0.00 0.00 2.59 5.51 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 57.67% 8.33% 0.00% 0.00% 38.60% 18.15% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.60 0.06 246.66 3.45 0.56 1.33 2.29 0.56
Enterprise Value to Revenue (EV/Rev)		 0.00 0.44 0.01 12.71 0.50 0.44 1.59 1.64 0.43
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 4.60 0.00 0.00 1.20 2.37 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 4.84 0.00 0.00 1.21 3.30 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 14.64 0.00 0.00 1.39 8.35 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 134.48 1.89 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 88.02 2.27 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 4.35 0.18 0.11 0.00 0.00 0.00 0.09 0.12
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.05
Financial Leverage		 0.00 2.09 0.11 -0.73 -0.81 -0.46 -0.21 -0.27 -0.14
Leverage Ratio		 0.00 5.82 2.58 1.82 1.71 1.36 1.23 1.56 1.51
Compound Leverage Factor		 0.00 4.74 2.61 1.77 1.71 1.40 1.23 1.56 1.53
Debt to Total Capital		 0.00% 81.32% 15.53% 10.12% 0.00% 0.00% 0.00% 8.25% 10.67%
Short-Term Debt to Total Capital		 0.00% 81.32% 15.53% 10.12% 0.00% 0.00% 0.00% 5.74% 5.82%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.51% 4.85%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 18.68% 84.47% 89.88% 100.00% 100.00% 100.00% 91.75% 89.33%
Debt to EBITDA		 0.00 4.05 -0.13 -0.26 0.00 0.00 0.00 -0.17 -0.33
Net Debt to EBITDA		 0.00 1.94 0.41 2.16 0.00 0.00 0.00 0.50 0.18
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.05 -0.15
Debt to NOPAT		 0.00 12.90 -0.17 -0.27 0.00 0.00 0.00 -0.15 -0.67
Net Debt to NOPAT		 0.00 6.19 0.55 2.30 0.00 0.00 0.00 0.46 0.36
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.05 -0.30
Altman Z-Score		 0.00 3.09 -1.70 4.65 4.37 5.59 -0.97 -0.03 -0.25
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.00 1.18 3.30 1.70 2.53 7.38 2.69 1.87 3.31
Quick Ratio		 0.00 0.24 1.86 0.78 1.29 1.35 0.73 0.55 0.76
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -97 -38 9.94 169 -361 -34 -101 -294
Operating Cash Flow to CapEx		 0.00% -51.59% -3,341.98% 2,748.35% 3,599.34% -1,029.03% -12,155.36% -1,893.95% -1,133.57%
Free Cash Flow to Firm to Interest Expense		 0.00 -12.50 -13.35 18.02 0.00 0.00 0.00 -193.21 -149.39
Operating Cash Flow to Interest Expense		 0.00 -0.24 -13.98 11.79 0.00 0.00 0.00 -382.46 -137.95
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -0.71 -14.39 11.36 0.00 0.00 0.00 -402.65 -150.12
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 1.93 1.18 0.46 1.48 0.83 0.36 0.56 0.99
Accounts Receivable Turnover		 0.00 113.88 105.56 91.28 1,339.38 0.00 0.00 119.41 50.93
Inventory Turnover		 0.00 3.75 4.91 2.01 4.08 2.48 2.56 2.99 3.55
Fixed Asset Turnover		 0.00 96.87 55.89 26.89 49.86 11.38 3.68 7.74 12.58
Accounts Payable Turnover		 0.00 46.51 26.39 6.31 23.42 21.49 39.42 34.98 24.69
Days Sales Outstanding (DSO)		 0.00 3.21 3.46 4.00 0.27 0.00 0.00 3.06 7.17
Days Inventory Outstanding (DIO)		 0.00 97.29 74.35 181.89 89.41 146.92 142.82 122.26 102.88
Days Payable Outstanding (DPO)		 0.00 7.85 13.83 57.82 15.58 16.99 9.26 10.43 14.78
Cash Conversion Cycle (CCC)		 0.00 92.65 63.98 128.07 74.10 129.93 133.56 114.88 95.27
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 0.00 108 41 3.55 111 506 252 194 409
Invested Capital Turnover		 0.00 7.26 2.74 3.10 13.50 2.11 0.56 1.21 1.76
Increase / (Decrease) in Invested Capital		 0.00 108 -68 -37 107 395 -254 -58 215
Enterprise Value (EV)		 0.00 173 2.35 875 383 284 336 443 229
Market Capitalization		 100 100 61 938 814 385 432 516 257
Book Value per Share		 $0.00 $0.02 $0.05 $0.03 $0.22 $0.22 $0.12 $0.07 $0.06
Tangible Book Value per Share		 $0.00 $0.02 $0.05 $0.03 $0.22 $0.22 $0.12 $0.07 $0.06
Total Capital		 0.00 188 118 74 543 608 348 290 490
Total Debt		 0.00 153 18 7.49 0.00 0.00 0.00 24 52
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.28 24
Net Debt		 0.00 73 -59 -63 -432 -102 -96 -73 -29
Capital Expenditures (CapEx)		 -0.18 3.59 1.20 0.24 5.62 18 1.02 11 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 103 35 0.81 72 379 132 76 250
Debt-free Net Working Capital (DFNWC)		 0.00 183 112 71 500 480 228 172 331
Net Working Capital (NWC)		 0.00 30 94 64 500 480 228 155 302
Net Nonoperating Expense (NNE)		 -6.09 -5.98 43 5.75 -33 -36 127 91 132
Net Nonoperating Obligations (NNO)		 0.00 73 -59 -63 -432 -102 -96 -73 -29
Total Depreciation and Amortization (D&A)		 1.39 1.91 4.90 4.81 2.19 34 60 28 48
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 26.26% 17.37% 1.17% 9.27% 58.16% 62.58% 28.08% 47.18%
Debt-free Net Working Capital to Revenue		 0.00% 46.42% 55.04% 103.52% 64.74% 73.74% 108.04% 63.90% 62.43%
Net Working Capital to Revenue		 0.00% 7.64% 46.08% 92.64% 64.74% 73.74% 108.04% 57.72% 57.05%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($6.90) ($1.41) $12.45 $2.75 ($16.06) ($6.13) ($2.99)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 2.15B 2.35B 2.52B 2.56B 2.58B 4.07B 7.04B
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($6.90) ($9.17) $12.18 $2.74 ($16.06) ($6.13) ($2.99)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 2.15B 2.35B 2.58B 2.58B 2.58B 4.07B 7.04B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 2.37B 2.37B 2.80B 2.80B 3.77B 5.59B 10.74B
Normalized Net Operating Profit after Tax (NOPAT)		 52 12 -106 -27 276 40 -270 -156 -73
Normalized NOPAT Margin		 25.70% 3.01% -51.89% -39.70% 35.72% 6.17% -127.45% -57.97% -13.69%
Pre Tax Income Margin		 30.65% 7.40% -72.72% -48.05% 41.00% 13.56% -220.12% -63.96% -39.17%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 0.00 4.63 -50.97 -61.47 0.00 0.00 0.00 -330.68 -104.67
NOPAT to Interest Expense		 0.00 1.53 -36.84 -49.54 0.00 0.00 0.00 -305.17 -39.96
EBIT Less CapEx to Interest Expense		 0.00 4.17 -51.39 -61.90 0.00 0.00 0.00 -350.87 -116.84
NOPAT Less CapEx to Interest Expense		 0.00 1.07 -37.26 -49.97 0.00 0.00 0.00 -325.36 -52.13
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% -14.32% 5.52% 62.95% 0.00% 0.00% -2.38%

Quarterly Metrics And Ratios for Canaan

No quarterly metrics and ratios for Canaan are available.


Financials Breakdown Chart

Canaan Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Canaan's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Canaan's net income appears to be on an upward trend, with a most recent value of -$210.27 million in 2025, falling from $57.67 million in 2017. The previous period was -$249.75 million in 2024. See Canaan's forecast for analyst expectations on what's next for the company.

Canaan's total operating income in 2025 was -$112.23 million, based on the following breakdown:
  • Total Gross Profit: $41.16 million
  • Total Operating Expenses: $153.39 million

Over the last 8 years, Canaan's total revenue changed from $200.72 million in 2017 to $529.74 million in 2025, a change of 163.9%.

Canaan's total liabilities were at $165.52 million at the end of 2025, a 15.9% decrease from 2024, and a 2.1% decrease since 2018.

In the past 7 years, Canaan's cash and equivalents has ranged from $37.69 million in 2018 to $421.23 million in 2021, and is currently $80.78 million as of their latest financial filing in 2025.

Over the last 8 years, Canaan's book value per share changed from 0.00 in 2017 to 0.06 in 2025, a change of 6.2%.


Related Companies

Financial statements for NASDAQ:CAN last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel